Stay updated with breaking news from Juventas Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Juventas Cell Therapy Ltd. announces China National Medical Product Administration (NMPA) has approved its New Drug Application (NDA) for Inatic...
DUBLIN--(BUSINESS WIRE)--The "CAR T - Cell Therapy - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about 250+ companies and 500+ drugs in CAR T - Cell Therapy Competitive landscape. It covers the therapeutics assessment by product...